Validation of endogenous reference genes for qRT-PCR analysis of human visceral adipose samples

BMC Molecular Biology

Volumn 11, Issue , 2010, Pages

  Mehta, Rohini ^a,b   Birerdinc, Aybike ^a,b   Hossain, Noreen ^b,c   Afendy, Arian ^b,c   Chandhoke, Vikas ^a,b   Younossi, Zobair ^a,b,c   Baranova, Ancha ^a,b  

^a GEORGE MASON UNIVERSITY   (United States)

^b BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^c INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BETA ACTIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE 1; POLYPEPTIDE; RNA; RNA POLYMERASE II; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE; UBIQUITIN C; UNCLASSIFIED DRUG; ZETA POLYPEPTIDE; ACTIN; MACROGLOBULIN; RNA 18S;

ABDOMINAL OBESITY; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENETIC ALGORITHM; GENETIC STABILITY; HUMAN; HUMAN TISSUE; INTRAABDOMINAL FAT; MORBID OBESITY; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION PROCESS; ALGORITHM; GENETICS; METABOLISM; METHODOLOGY; OBESITY; STANDARD; VALIDATION STUDY;

ACTINS; ALGORITHMS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INTRA-ABDOMINAL FAT; MACROGLOBULINS; OBESITY; REFERENCE STANDARDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA POLYMERASE II; RNA, RIBOSOMAL, 18S; SOFTWARE; UBIQUITIN C;

EID: 77952445492     PISSN: None     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-11-39     Document Type: Article

References (27)

1. Gomez-Ambrosi J, Catalan V, Diez-Caballero A, et al. Gene expression profile of omental adipose tissue in human obesity. FASEB J 2003, 03-0591fje.
2. Catalán V, Gómez-Ambrosi J, Rotellar F, et al. Validation of Endogenous Control Genes in Human Adipose Tissue: Relevance to Obesity and Obesity-associated Type 2 Diabetes Mellitus. Horm Metab Res 2007, 39:495-500. 10.1055/s-2007-982502, 17611901.
3. Bosello O, Zamboni M. Visceral obesity and metabolic syndrome. Obesity Reviews 2000, 1:47-56. 10.1046/j.1467-789x.2000.00008.x, 12119645.
4. Linder K, Arner P, Flores-Morales A, Tollet-Egnell P, Norstedt G. Differentially expressed genes in visceral or subcutaneous adipose tissue of obese men and women. J Lipid Res 2004, 45:154. 148.
5. Shoelson S, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007, 132:2180. 2169.
6. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004, 114:1752-1761. 535065, 15599400.
7. Grundy SM. Obesity, Metabolic Syndrome, and Cardiovascular Disease. J Clin Endocrinol Metab 2004, 89:2595-2600. 10.1210/jc.2004-0372, 15181029.
8. Hamaguchi M, Kojima T, Takeda N, et al. The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease. Annals of Internal Medicine 2005, 143:722-728.
9. Hanley AJG, Williams K, Festa A, et al. Liver Markers and Development of the Metabolic Syndrome. Diabetes 2005, 54:3140-3147. 10.2337/diabetes.54.11.3140, 16249437.
10. Rafiq N, Younossi ZM. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C. Expert Review of Gastroenterology & Hepatology 2008, 2:207-215.
11. Kim S, Kim T. Benchmarks - Selection of optimal internal controls for gene expression profiling of liver disease. Biotechniques 2003, 35:456.
12. Younossi ZM. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Alimentary Pharmacology & Therapeutics 2008, 28:2-12.
13. Garg A, Misra A. Hepatic Steatosis, Insulin Resistance, and Adipose Tissue Disorders. J Clin Endocrinol Metab 2002, 87:3019-3022. 10.1210/jc.87.7.3019, 12107193.
14. Tilg H, Hotamisligil GS. Nonalcoholic Fatty Liver Disease: Cytokine-Adipokine Interplay and Regulation of Insulin Resistance. Gastroenterology 2006, 131:934-945. 10.1053/j.gastro.2006.05.054, 16952562.
15. de Jonge HJM, Fehrmann RSN, de Bont ESJM, et al. Evidence based selection of housekeeping genes. PloS one 2007, 2(9):e898. 10.1371/journal.pone.0000898, 1976390, 17878933.
16. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 2002, 3:research0034.1-research0034.11.
17. Huggett J, Dheda K, Bustin S, Zumla A. Real-time RT-PCR normalisation; strategies and considerations. Genes and Immunity 2005, 6:279-284. 10.1038/sj.gene.6364190, 15815687.
18. Suzuki T, Higgins PJ, Crawford DR. Reviews - Control Selection for RNA Quantitation. Biotechniques 2000, 29:332.
19. Thellin O, Zorzi W, Lakaye B, et al. Housekeeping genes as internal standards: use and limits. Journal of Biotechnology 1999, 75:291-295. 10.1016/S0168-1656(99)00163-7, 10617337.
20. Bustin S. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. Journal of molecular endocrinology 2000, 25:193. 169.
21. Schmittgen TD, Zakrajsek BA. Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. Journal of Biochemical and Biophysical Methods 2000, 46:69-81. 10.1016/S0165-022X(00)00129-9, 11086195.
22. Vandesompele J, Kubista M, Pfaffl MW. Reference Gene Validation Software for Improved Normalization. Real-time PCR: current technology and applications 2009, 47:64. Norfolk, UK: Caister Academic Press, Logan J, Edwards K, Saunders N.
23. Andersen C, Jensen J, Ørntoft T. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004, 64:5250. 5245.
24. Pfaffl M, Tichopad A, Prgomet C, Neuvians T. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper--Excel-based tool using pair-wise correlations. Biotechnology letters 2004, 26:509-515. 10.1023/B:BILE.0000019559.84305.47, 15127793.
25. Dheda K, Huggett J, Chang J, et al. The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization. Analytical Biochemistry 2005, 344:141-143. 10.1016/j.ab.2005.05.022, 16054107.
26. Baranova A, Hammarsund M, Ivanov D, et al. Distinct organization of the candidate tumor suppressor gene RFP2 in human and mouse: multiple mRNA isoforms in both species- and human-specific antisense transcript RFP2OS. Gene 2003, 321:103-112. 10.1016/j.gene.2003.08.007, 14636997.
27. Rasmussen R. Quantification on the LightCycler instrument. Rapid Cycle Real-Time PCR: Methods and Applications 2001, 21-34. Heidelberg: Springer-Verlag Press, Meuer S, Wittwer C, Nakagawara K.